Search results
I Have Incontinence. How Can I Avoid Accidents When I Leave Home?
New York Times· 3 days agoQ: I’m going on vacation soon and am worried about leaks from urinary incontinence. Urinary...
MDMA Therapy for PTSD? FDA considers first psychedelic drug
KNBN Rapid City· 7 days agoFederal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club...
Tate Modern: Family proud of progress of boy thrown from balcony
BBC News· 4 days agoThe family of a boy who was thrown from the 10th floor of London's Tate Modern art gallery have said...
Why Is My Dog Shaking? Veterinarians Weigh In — Best Life
Best Life· 4 days agoKeeping an eye on your dog's health can be challenging. Spotting and treating an issue with your dog...
After stroke, York woman finds herself by writing children’s books
Daily Press· 2 days agoEight years ago, Tiffany Rebar was sitting in her living room, 34 weeks pregnant and sewing a...
Yakima police domestic violence coalition meeting highlights strangulation dangers
KIMA Yakima· 3 days ago"It's a form of asphyxia that is caused by external compression of the neck that leads to closure of...
Blues pulled off 'Monday Night Miracle' 3 years after nearly moving to Saskatoon | NHL.com
NHL· 2 days agoLegendary hockey reporter Stan Fischler writes a weekly scrapbook for NHL.com. Fischler, known as...
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D...
Morningstar· 3 days agoFN Media Group News Commentary - In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National ...
Accessing Alzheimer's Disease care a long road for patients
The Bradford Era· 5 days agoAs the prevalence of Alzheimer’s Disease and related cognitive conditions rises in Pennsylvania,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 6 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...